Acute Porphyria Drugs

Monograph

B01AA03 - Warfarin
Propably not porphyrinogenic
PNP

Rationale
Metabolised by CYP 2C but no data pointing to CYP-induction. Three references consider it safe.
Chemical description
Vitamin-K antagonist. Metabolized by CYP 2C9. No data pointing to CYP-induction. South African list: use. Kalman, Bonkowski: safe. Michael Moore: safe. C.Andersson; patient reports: tolerated (n=3)
IPNet drug reports
Uneventful use reported in 20 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AA or go back.
References
Tradenames

Marevan Aldocumar Marfarin · Warfarin Coumadin Coumadin · Marevan · Warfarin Marevan · Warfarin Aldocumar · Marevan · Warfarin Warfin Marevan Warfarin Marevan · Marevan Forte · Warfarin Orfarin · Warfarin · Warfarin–Grindeks Orfarin · Warfarin Marevan · Marevan Forte Farin Marevan · Marivarin · Natrijev varfarinat
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙